The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society
Jazyk angličtina Země Irsko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
26117398
DOI
10.1016/j.atherosclerosis.2015.05.007
PII: S0021-9150(15)01308-8
Knihovny.cz E-zdroje
- Klíčová slova
- Ankle-brachial index, Arterial stiffness, Carotid ultrasonography, Central haemodynamics, Circulating biomarkers, Endothelial function, Vascular biomarkers, Wave reflections,
- MeSH
- analýza nákladů a výnosů MeSH
- arteriae carotides diagnostické zobrazování MeSH
- biologické markery krev metabolismus MeSH
- C-reaktivní protein metabolismus MeSH
- hemodynamika MeSH
- intimomediální šíře tepenné stěny MeSH
- kardiologie normy MeSH
- kardiovaskulární nemoci krev diagnóza MeSH
- lidé MeSH
- primární prevence MeSH
- riziko MeSH
- rozhodování MeSH
- sekundární prevence MeSH
- společnosti lékařské MeSH
- stárnutí MeSH
- tlakový index kotník-paže MeSH
- tuhost cévní stěny MeSH
- ultrasonografie MeSH
- výsledek terapie MeSH
- výzkumný projekt MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
- Názvy látek
- biologické markery MeSH
- C-reaktivní protein MeSH
While risk scores are invaluable tools for adapted preventive strategies, a significant gap exists between predicted and actual event rates. Additional tools to further stratify the risk of patients at an individual level are biomarkers. A surrogate endpoint is a biomarker that is intended as a substitute for a clinical endpoint. In order to be considered as a surrogate endpoint of cardiovascular events, a biomarker should satisfy several criteria, such as proof of concept, prospective validation, incremental value, clinical utility, clinical outcomes, cost-effectiveness, ease of use, methodological consensus, and reference values. We scrutinized the role of peripheral (i.e. not related to coronary circulation) noninvasive vascular biomarkers for primary and secondary cardiovascular disease prevention. Most of the biomarkers examined fit within the concept of early vascular aging. Biomarkers that fulfill most of the criteria and, therefore, are close to being considered a clinical surrogate endpoint are carotid ultrasonography, ankle-brachial index and carotid-femoral pulse wave velocity; biomarkers that fulfill some, but not all of the criteria are brachial ankle pulse wave velocity, central haemodynamics/wave reflections and C-reactive protein; biomarkers that do no not at present fulfill essential criteria are flow-mediated dilation, endothelial peripheral arterial tonometry, oxidized LDL and dysfunctional HDL. Nevertheless, it is still unclear whether a specific vascular biomarker is overly superior. A prospective study in which all vascular biomarkers are measured is still lacking. In selected cases, the combined assessment of more than one biomarker may be required.
Cardiology Department Klinikum Wels Grieskirchen Wels Austria
Cardiology Unit Department of Medicine Karolinska University Hospital Solna 171 76 Stockholm Sweden
Clinica Medica Department of Clinical and Experimental Sciences University of Brescia Brescia Italy
Department of Angiology University Hospital Graz 8036 Graz Austria
Department of Cardiology Athens University Medical School Attikon University Hospital Athens Greece
Department of Cardiology Charité Universitätsmedizin Berlin 12203 Berlin Germany
Department of Cardiology Dupuytren University Hospital Limoges France
Department of Cardiology Tokyo Medical University 160 0023 Tokyo Japan
Department of Cardiology University of Ioannina Medical School Ioannina Greece
Department of Cardiology Wales Heart Research Institute Cardiff CF14 4XN United Kingdom
Department of Vascular Surgery Rigshospitalet University of Copenhagen Denmark
Division of Vascular Medicine Ospedale San Giovanni 6500 Bellinzona Switzerland
Heymans Institute of Pharmacology Ghent University 9000 Ghent Belgium
Citace poskytuje Crossref.org